Gene transfer of interleukin 13 receptor α2 chain dramatically enhances the antitumor effect of IL-13 receptor-targeted cytotoxin in human prostate cancer xenografts

Cancer Gene Therapy

Volumn 8, Issue 11, 2001, Pages 861-868

  Kawakami, Koji ^a   Husain, Syed R ^a   Bright, Robert K ^b   Puri, Raj K ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b EARLE A CHILES RESEARCH INSTITUTE   (United States)

Author keywords

Cytotoxin therapy; Gene therapy; Interleukin 13 receptor; Prostate cancer; Pseudomonas exotoxin; Sensitization

Indexed keywords

CYTOTOXIN; INTERLEUKIN 13 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CYTOTOXICITY; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PSEUDOMONAS; SENSITIZATION; TUMOR XENOGRAFT;

ADP RIBOSE TRANSFERASES; ANIMALS; BACTERIAL TOXINS; EXOTOXINS; GENE THERAPY; HUMANS; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; MALE; MICE; MICE, NUDE; PROSTATIC NEOPLASMS; PSEUDOMONAS AERUGINOSA; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-13; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VIRULENCE FACTORS;

ANIMALIA; PSEUDOMONAS; PSEUDOMONAS EXOTOXIN;

EID: 0035191656     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700373     Document Type: Article

References (36)

1. Prostate cancer: Numbers may not tell the whole story
2. Targeting human prostatic carcinoma through basic fibroblast growth factor receptors in an animal model: Characterizing and circumventing mechanisms of tumor resistance
3. Redesigning nature's poisons to create antitumor reagents
4. Recombinant toxins for cancer treatment
5. Immunotoxins for the treatment of leukemia
6. Targeting diphtheria toxin to growth factor receptors
7. Immunotoxins for central nervous system malignancy
8. Development of a recombinant interleukin-4-Pseudomonas exotoxin for therapy of glioblastoma
9. Receptor for interleukin 13: Interaction with interleukin 4 by a mechanism that does not involve the common γ chain shared by receptors for interleukins 2, 4, 7, 9, and 15
10. A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4
11. Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR)
12. Receptor for interleukin-13 on AIDS-associated Kaposi's sarcoma cells served as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein
13. Interleukin-13 fusion cytotoxin as a potent targeted agent for AIDS-Kaposi's sarcoma xenograft
14. IL-13 receptor α chain: A novel tumor associated transmembrane protein in primary explants of human malignant gliomas
15. The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor
16. c chain of the IL-2 receptor
17. Human ovarian carcinoma cell lines express IL-4 and IL-13 receptors: Comparison between IL-4- and IL-13-induced signal transduction
18. Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway
19. Structure of and signal transduction through interleukin-4 and interleukin-13 receptors
20. cDNA cloning and characterization of the human interleukin 13 receptor α chain
21. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor
22. Cloning of the human IL-13Rα1 chain and reconstitution with the IL-4Rα of a functional IL-4/IL-13 receptor complex
23. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α chain
24. The interleukin-13 receptor α2 chain: An essential component for binding and internalization but not for IL-13 induced signal transduction through STAT6 pathway
25. Structure of IL-13 receptor: Analysis of subunit composition in cancer and immune cells
26. Sensitization of cancer cells to interleukin 13-Pseudomonas exotoxin-induced cell death by gene transfer of interleukin 13 receptor α chain
27. Interleukin-13 receptors on human prostate carcinoma cell lines represent a novel target for a chimeric protein composed of IL-13 and a mutated form of Pseudomonas exotoxin
28. Conversion of interleukin-13 into a high affinity agonist by a single amino acid substitution
29. Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens
30. Interleukin-13 receptor α but not α chain: A functional component of interleukin-4 receptors
31. Expression of high affinity interleukin-4 receptors on human renal carcinoma cells and inhibition of tumor growth in vitro by interleukin-4
32. Ligand: A versatile computerized approach for characterization of ligand-binding systems
33. Expression of high affinity IL4 receptors on murine sarcoma cells and receptor mediated cytotoxicity of tumor cells to chimeric protein between IL-4 and Pseudomonas exotoxin
34. Thymidine kinase obliteration: Creation of transgenic mice with controlled immune deficiency
35. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system
36. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells